These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3860304)

  • 1. Comparative murine metabolism and disposition of class II anthracycline antibiotics.
    Dodion P; Egorin MJ; Riggs CE; Ferraro TA; Tamburini JM; Bachur NR
    Cancer Chemother Pharmacol; 1985; 15(2):153-60. PubMed ID: 3860304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine metabolism and disposition of marcellomycin.
    Dodion P; Egorin MJ; Tamburini JM; Riggs CE; Bachur NR
    Drug Metab Dispos; 1984; 12(2):209-16. PubMed ID: 6144487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacokinetics of marcellomycin.
    Dodion P; Rozencweig M; Nicaise C; Watthieu M; Tamburini JM; Riggs CE; Bachur NR
    Cancer Chemother Pharmacol; 1985; 14(1):42-8. PubMed ID: 3965159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative anthracycline metabolism in rats: loss of marcellomycin fluorescence.
    Dodion P; Tamburini JM; Fox BM; Riggs CE; Bachur NR
    Cancer Res; 1986 Jun; 46(6):2714-9. PubMed ID: 3084076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
    Steinheider G; Westendorf J; Marquardt H
    Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
    Seeber S; Loth H; Crooke ST
    J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of the new anthracycline antibiotic, menogarol, in mice.
    Dodion P; Chang BK; Egorin MJ; Olman EA; Engisch KL; Bachur NR
    Drug Metab Dispos; 1984; 12(3):365-70. PubMed ID: 6145565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kinetics of aclacinomycin A and its major metabolites in man.
    Egorin MJ; Van Echo D; Fox BM; Whitacre M; Bachur NR
    Cancer Chemother Pharmacol; 1982; 8(1):41-6. PubMed ID: 6954015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.
    Steinheider G; Schaefer A; Westendorf J; Marquardt H
    Cell Biol Toxicol; 1988 Mar; 4(1):123-33. PubMed ID: 3228706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of aclacinomycin A in mice, rabbits and dogs by photometric assay (author's transl)].
    Iguchi H; Matsushita Y; Ohmori K; Hirano S; Kiyosaki T; Hori S; Tone H; Oki T
    Jpn J Antibiot; 1980 Feb; 33(2):179-91. PubMed ID: 6929360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclacinomycin tissue distribution in the rat.
    Mazzanti L; Scalori V; Mian M; Alessandrì MG; Giovannini L
    Chemioterapia; 1988 Feb; 7(1):49-52. PubMed ID: 3378277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells.
    Ando S; Nakamura T; Kagawa D; Ueda T; Nishimura T; Kubo A; Tsutani H; Sasada M; Uchino H
    Cancer Treat Rep; 1986 Jul; 70(7):835-41. PubMed ID: 3459574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study.
    Karanes C; Young JD; Samson MK; Smith LB; Franco LA; Baker LH
    Invest New Drugs; 1983; 1(2):173-9. PubMed ID: 6590531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline assay by high-pressure liquid chromatography.
    Averbuch SD; Finkelstein TT; Fandrich SE; Reich SD
    J Pharm Sci; 1981 Mar; 70(3):265-9. PubMed ID: 6943332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.
    Dodion P; Bernstein AL; Fox BM; Bachur NR
    Cancer Res; 1987 Feb; 47(4):1036-9. PubMed ID: 3467841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits (author's transl)].
    Iguchi H; Seryu Y; Kiyosaki T; Hori S; Tone H; Oki T
    Jpn J Antibiot; 1980 Feb; 33(2):169-78. PubMed ID: 6929359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
    Morin MJ; Sartorelli AC
    Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.